Lightstone Ventures @LightstoneVC
Dedicated to empowering entrepreneurs with the resources and guidance needed to bring their innovative therapeutics to patients. lightstonevc.com Joined August 2021-
Tweets47
-
Followers110
-
Following122
-
Likes1
Congrats to @Tagworkspharma on this significant milestone! Great news for patients as the Company enters clinical development of their Phase 1 trial of TGW101, a first-in-class antibody drug-conjugate targeting tumor associated glycoprotein 72 (TAG-72) in advanced #solidtumors.
Congrats to @Tagworkspharma on this significant milestone! Great news for patients as the Company enters clinical development of their Phase 1 trial of TGW101, a first-in-class antibody drug-conjugate targeting tumor associated glycoprotein 72 (TAG-72) in advanced #solidtumors.
Please join us in welcoming H. Martin Seidel, Ph.D., to the Lightstone team as Advisor. Dr. Seidel brings over 30 years of experience across R&D and Business Development in both pharma and biotech to our team. We look forward to working with you!
Congratulations to Brendan Kelly, PhD, on his promotion to Principal at Lightstone Ventures! As a core member of our investment team, we celebrate Brendan’s leadership and contributions across our portfolio. We look forward to continuing our exciting work together!
We welcome Ken Mills as CEO and member of the Board of Directors for @Tagworkspharma as the company expects to embark on its next phase of growth and enter the clinic in 2025 with its lead antibody-drug conjugate program, TGW101.
We welcome Ken Mills as CEO and member of the Board of Directors for @Tagworkspharma as the company expects to embark on its next phase of growth and enter the clinic in 2025 with its lead antibody-drug conjugate program, TGW101.
Lightstone portfolio company @VoltaMedical announced positive results from their TAILORED-AF trial, comparing AI-assisted ablation procedure with the conventional treatment for persistent atrial fibrillation patients. Learn more about what was presented: bit.ly/3yEkKXW
Congrats to @cerevance, who announced the closing of their Series B-1 Extension financing round. Lightstone is a proud fund partner, and we look forward to company updates as they progress their pipeline of therapies for CNS diseases. Read more: bit.ly/44jBxeS
Congrats to @cerevance, who announced the closing of their Series B-1 Extension financing round. Lightstone is a proud fund partner, and we look forward to company updates as they progress their pipeline of therapies for CNS diseases. Read more: bit.ly/44jBxeS
Welcome José-Alain Sahel, M.D., to Lightstone, joining us as an advisor. A distinguished professor and leader in the Ophthalmology and Neuroscience space, Dr. Sahel’s deep knowledge will play a key role in supporting new and existing portfolio companies.
Congratulations to Jingjing Wang, Ph.D. on her promotion to Vice President at Lightstone! As a core member of our investment team, we look forward to exciting things to come as we continue our work together.
Congratulations to @RelievantMed, that has developed and commercialized the Intracept® Procedure, their FDA-cleared treatment for chronic #vertebrogenic pain, on being acquired by @bostonsci! Great news and great for patients. Learn more here: bit.ly/3sNpJTH
Congratulations to @RelievantMed, that has developed and commercialized the Intracept® Procedure, their FDA-cleared treatment for chronic #vertebrogenic pain, on being acquired by @bostonsci! Great news and great for patients. Learn more here: bit.ly/3sNpJTH
Exciting news from @cerevance, who dosed the first patient in their ASCEND Phase 2 clinical study of CVN424 for the treatment of individuals with Parkinson’s Disease. We look forward to future updates! Full press release: bit.ly/49CufF4
Exciting news from @cerevance, who dosed the first patient in their ASCEND Phase 2 clinical study of CVN424 for the treatment of individuals with Parkinson’s Disease. We look forward to future updates! Full press release: bit.ly/49CufF4
Today, the launch of 65LAB was announced, a company creation vehicle designed to advance drug discovery & new therapeutics companies in Singapore. As a proud founding partner, we look forward to the potential patient impact of these discoveries. Read more: prn.to/3LJD0TO
Today, @AlxOncology shared encouraging positive interim Phase 2 data from their ASPEN-06 clinical trial evaluating evorpacept, for the treatment of advanced HER2-positive gastric cancer. Full press release here: bit.ly/45fZ8fe
Today, @AlxOncology shared encouraging positive interim Phase 2 data from their ASPEN-06 clinical trial evaluating evorpacept, for the treatment of advanced HER2-positive gastric cancer. Full press release here: bit.ly/45fZ8fe
Sharing an exciting update from @cerevance, who recently announced that the first patient has been dosed in their Phase 1 study evaluating safety and tolerability of CVN293, for the treatment of #ALS and #Alzheimers. Full press release: bit.ly/3Lyr4nL
Sharing an exciting update from @cerevance, who recently announced that the first patient has been dosed in their Phase 1 study evaluating safety and tolerability of CVN293, for the treatment of #ALS and #Alzheimers. Full press release: bit.ly/3Lyr4nL
Congrats @RelievantMed, whose agreement to be acquired by @bostonsci was announced. The company’s therapy, the Intracept® Procedure, is their FDA-cleared treatment for chronic #vertebrogenic pain. Great news and great for patients! Learn more here: bit.ly/3EP7fEE
Congratulations to @NimbusTx, on the closing of their $210 million private financing! Lightstone is a proud fund partner, and we look forward to updates as the company advances their pipeline in immunology, cancer and metabolic disease. Learn more: bit.ly/3LfQSF4
Congratulations to @NimbusTx, on the closing of their $210 million private financing! Lightstone is a proud fund partner, and we look forward to updates as the company advances their pipeline in immunology, cancer and metabolic disease. Learn more: bit.ly/3LfQSF4
Congrats to @cerevance for being named one of @FierceBiotech’s 2023 #Fierce15 biotech companies. We’re looking forward to seeing more great accomplishments from Cerevance in the future!
Congrats to @cerevance for being named one of @FierceBiotech’s 2023 #Fierce15 biotech companies. We’re looking forward to seeing more great accomplishments from Cerevance in the future!
Congrats to @FIRE1_HF on successfully implanting the first U.S. patients with its FIRE1™ System for remote heart failure monitoring in a study that will assess the Company’s technology to improve outcomes for heart failure patients. Learn more: bwnews.pr/3Dl7ab7
Congrats to @FIRE1_HF on successfully implanting the first U.S. patients with its FIRE1™ System for remote heart failure monitoring in a study that will assess the Company’s technology to improve outcomes for heart failure patients. Learn more: bwnews.pr/3Dl7ab7
Congrats to @Tagworkspharma, on the closing of their Series A financing! Lightstone is a proud fund partner, and we look forward to updates as the company advances their lead ADC program, TGW101, and their proprietary Click-to-Release platform. Learn more: tagworkspharma.com/tagworks-pharm…
Congrats to @Tagworkspharma, on the closing of their Series A financing! Lightstone is a proud fund partner, and we look forward to updates as the company advances their lead ADC program, TGW101, and their proprietary Click-to-Release platform. Learn more: tagworkspharma.com/tagworks-pharm…
Lightstone portfolio company, @RelievantMed, recently announced the publication of three-year pooled results from the #Intracept Procedure, demonstrating long-term pain relief and reduced opioid use for patients with vertebrogenic pain. Learn more: bit.ly/3PaZi3g
Lightstone portfolio company, @RelievantMed, recently announced the publication of three-year pooled results from the #Intracept Procedure, demonstrating long-term pain relief and reduced opioid use for patients with vertebrogenic pain. Learn more: bit.ly/3PaZi3g
This Thursday at #BIO2023, Lightstone Partner Christina Isacson, will discuss the role of health systems within the commercialization of new therapies alongside fellow industry experts. Panel details here: bit.ly/3Nd0Acz
FactorInvestor🇺�... @Sloukod3354
62 Followers 2K Following 15-30% Monthly | 2 High-Conviction Stocks.Short-Term Gains: 15-20% in Days/Weeks.DM "JOIN" for WhatsApp Alerts. Live Trade Signals • Market Analysis
Kaustubh Nath @nath_kaustubh
172 Followers 1K Following Investment Professional @IAN | Views are personal
Falahuddin @Falahuddin23
267 Followers 7K Following Crypto, Metaverse, Web3, Nexus, AI, computer scientist, IT system integrator turned digital angel investor #Sandbox 8x #Solana 22x #OM 6x
SeanRoboticsAILLMVLM @SeanRoboticsAI
29 Followers 3K Following
Marco @marcoemargan
348 Followers 5K Following
Wei Lun Ng @WeiLunNg1
48 Followers 289 Following Tiny scientist at Duke-NUS Singapore. Interested in RNA, aging, bat immunology
zeus @leadgakusei
80 Followers 3K Following Building a one man 10k per month appointment setting business in 10 months . sharing insights along the way. follow to find out if i fail
Raul @Lagartolindo787
0 Followers 35 Following
Medsider @medsider
51 Followers 278 Following We unpack the insights, tactics, and secrets behind the most successful medtech and healthtech startups in the world.
CureMatch @CureMatch
1K Followers 3K Following #PrecisionMedicine company, empowering #oncologists with personalized treatment options for patients with #cancer
Layla Starr @laylainlab
255 Followers 718 Following fka Layla Ghaffari // Scientist @synapticure 🧠⚡️ if I'm not talking about science, I'm talking about skiing 🎿 or movies 🎥
NVCA @nvca
22K Followers 2K Following The National Venture Capital Association (NVCA) is the venture capital industry’s trusted source for advocacy, professional development and industry research.
Yuanjin Zhang | 张�... @YuanjinZhang1
286 Followers 575 Following Chem Bio PhD student@Cravatt Lab, @ScrippsResearch. Bsc @PKU1898. She/her
Bayartis @BayartisHealth
28 Followers 124 Following Bayartis solutions helps patients store and manage medications and avoid the problems of #polypharmacy
HealthInvestor UK @HealthInvestor
4K Followers 4K Following Essential reading for health and social care businesses.
❤Scott S Cooper❤ @SSscoop475
298K Followers 319K Following ♏♂(スコット)FEED THE NEEDY & ENLIGHTEN THE GREEDY! ❤TIBETAN BUDDHIST ❤@Tashaeva ❤#TM1DN _ ❤#TeamUnidoS ❤@1LA_Lady ❤@ynovak ❤@Stelanovaeva❤@oksana_tasha
Ankush Sharma @Biologynerd2
295 Followers 4K Following mTor || Preclinical Studies || Oncology Models
Sonia Chothani @SoniaChothani
182 Followers 312 Following Research Fellow. Computational biologist working on human health and disease. RNA Biology. Microproteins. Views are my own.
F-Prime @FPrimeCapital
3K Followers 373 Following We create and invest in healthcare and technology companies that impact lives all over the world.
Paul D'Agrosa @pdcicero2
0 Followers 53 Following
Kamran Anis @KamranAnis
238 Followers 2K Following Healthcare Technology Director, Avid Squash Player & Automotive Enthusiast
McNaboo @NabooMc70260
9 Followers 306 Following Mong sự yêu của em , Chỉ có phấn khởi và hạnh phúc . Ko buộn và Ko bị tổn thương
Study Project @study2324
29 Followers 418 Following
Donagh O'Shea @DonaghGOShea
176 Followers 285 Following PhD student @TissueEngDublin @RCSI_Irl 🧬 || Pharmacist 💊💉
Nishtha Sethi @therealshin00
7K Followers 5K Following MBA @iim_bangalore | Econ @UnivofDelhi | Francophone 🇫🇷 Fitness 🏋♀️🤸♀️ | Startups & VC 💰🚀 | Music 🎶 🎤
Jonathan Anderzon @hjanderzon
48 Followers 283 Following
Abroad International ... @abroadmove
2 Followers 15 Following 🌍 Your global relocation experts! Abroad Relocation offers seamless moves worldwide. With offices in Singapore, UAE, and India, we provide top-notch services.
Anshika Singh @lupinseverus
25 Followers 3K Following
Jamie Rintoul @JamieRintoul2
89 Followers 973 Following PhD candidate @UCL, working on next-gen CAR T cells | Love all things synbio x therapeutics 🧬 | Helping scientists translate @NucleateHQ 🚀
Mohd Khan, Ph.D. @Onc_khan
178 Followers 506 Following VP & Head BD @fortressbio | Prev @DeloitteUS | @BoozAllen| Ph.D. NIH's GPP @NIH @UMBaltimore | Ex-Grad Fellow @AAPSComms
Hu Cang @HuCang2
48 Followers 499 Following
Joseph @josephaaj
684 Followers 4K Following Stock Market Trader in Nifty etc. Also I do real estate deals around Chennai.
Curated Capital @CuratedCap
676 Followers 355 Following We empower the extraordinary—those rare entrepreneurs whose bold ideas are poised to transform the future.
Alex Hruska @alex_hruska
275 Followers 697 Following Bioengineer working on cancer mechanobiology | PhD @Brown_BME | Former VC Fellow @AmericanCancer @watermanvc, Research @DraperLab @theNCI
Jack Vailas @jack_vailas
6 Followers 117 Following
Eoghan Dunne @eoghandunne
182 Followers 446 Following MedTech Engineer and Senior Researcher @tmdlab | Engineer | Graduate @NUIGalway | Explorer & Adventurer
Anup Khanal @AnupKhanal91991
0 Followers 55 Following
One Chain Immunothera... @onechaintx
1K Followers 778 Following Spin-off company of the @Menendez_Lab, @CarrerasIJC & @icreacommunity, aiming to develop CAR-T candidates as a treatment for oncological diseases.
Ysios Capital @YsiosCapital
3K Followers 1K Following Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide. Sign up & stay tuned https://t.co/DACFv4zEV0 📩
Asia HealthTech News @AsianHealthTech
784 Followers 2K Following Latest developments in the Asian Healthcare market. We 💚 #healthtech, #medtech & #biotech. Follow us if you do too!
Tagworks Pharmaceutic... @Tagworkspharma
231 Followers 236 Following Delivering a new class of ADCs and targeted radionuclide therapies for solid tumors with our proprietary Click-to-Release treatment platform
Ruben Sebastian @RubenSebas_
813 Followers 2K Following Biotech investor & board member | Covering biotech, drug development, venture capital, startups and pharma | 🦋 https://t.co/TRDbxTdGBb
Eimear Dolan @EimearBDolan
1K Followers 988 Following SFI Royal Society University Research Fellow @Bio_Eng_NUIG Medical Implant Design. Co-founder @fadamedical Former @MIT_IMES @TCDengineering @RCSI_IRL
Cerevance @cerevance
246 Followers 194 Following Creating a world-class neuroscience company to advance new medicines for serious diseases
ZELTIQ @Zeltiq
127 Followers 1 Following ZELTIQ™ is a medical device company dedicated to the development of non-invasive procedures to help patients reduce unwanted body fat.
Vigil Neuroscience @VigilNeuro
392 Followers 111 Following Harnessing the power of microglia to improve the lives of patients, caregivers and families through transformative treatments for neurodegenerative diseases.
Verastem Oncology @VerastemOncolog
3K Followers 1K Following Verastem Oncology is committed to developing and commercializing medicines to improve the lives of patients with #RAS/MAPK-driven #cancers. $VSTM
Tizona Therapeutics @tizonatx
97 Followers 72 Following Tizona Therapeutics is harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases.
SetPoint Medical @SetPointMed
513 Followers 28 Following A revolutionary new treatment for rheumatoid arthritis. #StartActivating #SetPointSystem #SetPointTherapy Individual outcomes vary. Safety info: https://t.co/BhikdgoQHO
Second Genome @SecondGenome
2K Followers 46 Following Second Genome is discovering and developing transformational precision therapies.
Reprieve Cardiovascul... @ReprieveCardio
46 Followers 57 Following
Intracept by Boston S... @RelievantMed
356 Followers 12 Following The Intracept™ Procedure is the first and only FDA‑cleared procedure proven to relieve vertebrogenic low back pain.
Nimbus Therapeutics @NimbusTx
2K Followers 121 Following We integrate computational chemistry and other advanced technologies to design breakthrough medicines and transform drug development. https://t.co/gANxj1Ufzq
Terumo Neuro @terumoneuro
2K Followers 1K Following A global leader in neurovascular innovation, MicroVention is now Terumo Neuro.
Medisix Therapeutics @medisixtx
70 Followers 77 Following Medisix is an Immune Engineering CAR-T company targeting T-Cell malignancies 2017
Flex Pharma @flexpharma
511 Followers 95 Following Flex Pharma, Inc. is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders.
Earlens Corporation @Earlens
238 Followers 90 Following Earlens is transforming the hearing experience for millions of people who suffer from hearing loss.
CatamaranBio @CatamaranBio
123 Followers 3 Following Cell Therapy Company developing allogeneic, off-the-shelf products for patients with high unmet medical need
Calithera Biosciences @calithera
225 Followers 129 Following Calithera is pioneering the discovery and development of targeted, small molecule therapies to treat cancer and other life threatening diseases.
Cala Health® @CalaHealth
588 Followers 95 Following #CalaHealth is a bioelectronic medicine company transforming the standard of care for chronic disease. #EssentialTremor #Neuromodulation
ALX Oncology @AlxOncology
339 Followers 236 Following ALX Oncology is a clinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Allay Therapeutics @allaytx
36 Followers 144 Following Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation for patients and physicians.
Alchemab Therapeutics @alchemabtx
391 Followers 6 Following
Sonali Basak @sonalibasak
56K Followers 5K Following Chief Investment Strategist for iCapital. Previously anchor for @BloombergTV & journalist @business. @NYUStern MBA. Views are my own.
Bloomberg TV @BloombergTV
862K Followers 567 Following Breaking news. In-depth analysis. Market-moving scoops. Exclusive interviews. Sign up for the Wall Street Week newsletter: https://t.co/RPmABSzqpH
Leslie Picker @LesliePicker
29K Followers 2K Following CNBC Senior Banking & Finance Correspondent https://t.co/zFrCI92DJh
Barron's @barronsonline
388K Followers 39 Following The world's premier investing publication since 1921. For customer support, visit https://t.co/HkyUtq6BNr
Owen Thomas @owenthomas
19K Followers 10K Following Managing editor, @SFBusinessTimes. Former @protocol, @sfchronicle, etc. Always @alex's #Twitterdad. Email: othomas at bizjournals dot com
Biz Carson @bizcarson
26K Followers 2K Following Bloomberg reporter covering @wealth in CA. Ex-Protocol, Forbes, Business Insider, Gigaom, & Wired. Atlanta native, IU Hoosier. Email: [email protected]
Investors.com @IBDinvestors
418K Followers 587 Following Investor's Business Daily is guiding investors of all experience levels through the stock market using time-tested strategies and actionable insights.
Hannah Kuchler @hannahkuchler
19K Followers 5K Following Global pharma editor @FT, leading science and pharma team. Emmy-nominated, Loeb winner. Previously NY, SF, HK.
Joseph Cotterill @jsphctrl
34K Followers 1K Following Emerging Markets correspondent @FinancialTimes. I insist you go to Bluesky.
Miles Kruppa @MilesKruppa
4K Followers 2K Following Finance reporter at the @theinformation covering big money in AI. Previously reporter at the @WSJ and @FT. Get in touch: [email protected].
Financial Times @FinancialTimes
7.4M Followers 996 Following This account is now closed. For the best of FT journalism, including breaking news and analysis, follow @ft
Katie Jennings @katiedjennings
6K Followers 3K Following VP for comms & strategy @cbcny | Formerly @Forbes, @Bagehots, @POLITICO
Leah Rosenbaum @leah_rosenbaum
4K Followers 3K Following writer, editor, public health superfan. Formerly: @BusinessInsider, @Forbes, @UCBerkeleySPH, @ucbsoj.
Forbes @Forbes
20.8M Followers 5K Following Sign up now for Forbes' free daily newsletter for unmatched insights and exclusive reporting: https://t.co/LAKg7gIfDJ
Venture Capital Journ... @VCJournal
7K Followers 773 Following Twitter stream for readers of Venture Capital Journal.
Dealreporter @Dealreporter
11K Followers 273 Following An Acuris company, our news and data cover Mergers and Acquisitions, Special Situations and Equity Capital Markets (ECM) in real-time, with 67 global bureaus.
SteveGelsi @SteveGelsi
2K Followers 1K Following Staff news reporter focused on banking and cannabis at https://t.co/AFy0FUotys. Ex-private equity writer at The Deal and Buyouts magazine and other stuff.
The Deal by With Inte... @TheDealNewsroom
21K Followers 3K Following Our newsroom has been serving corporate dealmakers, advisers and institutional investors the most sophisticated analysis of the deal economy since 1999.
PE HUB @PEHUB
39K Followers 446 Following #privateequity #pe and #venturecapital #vc news, analysis and data.
Vishal Persaud @vishalpersaud
1K Followers 1K Following Tech PR media strategist @OffleashPR | Former Bloomberg, Business Insider | @dartmouth @newmarkjschool alum | Bronx, NY-born 🇬🇾, @yankees @nyknicks fan
April Joyner @aprjoy
4K Followers 2K Following Business + tech writer. Not posting here now: find me on Bluesky with the same handle.
Ben Bergman @thebenbergman
11K Followers 823 Following Senior Correspondent @BusinessInsider, investigating VC/startups. Big into tennis, skiing and poker. Got a tip? Message me securely on Signal: BenBergman.11
Insider @thisisinsider
409K Followers 617 Following What you want to know. Follow us on Facebook, Instagram, TikTok, and YouTube. Visit our homepage for the day's top stories.
The New York Times @nytimes
55.1M Followers 849 Following News tips? Share them here: https://t.co/ghL9OoYKMM
Trends for United States
You might like
